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Background: Despite epidemiological findings showing increased air pollution related cardiovascular diseases
(CVD), the knowledge of the involved molecular mechanisms remains moderate or weak. Particulate matter (PM)
produces a local strong inflammatory reaction in the pulmonary environment but there is no final evidence that
PM physically enters and deposits in blood vessels. Extracellular vesicles (EVs) and their miRNA cargo might be the
ideal candidate to mediate the effects of PM, since they could be potentially produced by the respiratory system,
reach the systemic circulation and lead to the development of cardiovascular effects.
The SPHERE (“Susceptibility to Particle Health Effects, miRNAs and Exosomes”) project was granted by ERC-2011-StG
282413, to examine possible molecular mechanisms underlying the effects of PM exposure in relation to health
outcomes.
Methods/design: The study population will include 2000 overweight (25 < BMI < 30 kg/cm2) or obese
(BMI ≥ 30 kg/cm2) subjects presenting at the Center for Obesity and Work (Fondazione IRCCS Ca’ Granda Ospedale
Maggiore Policlinico, Milan, Italy).
Each subject donates blood, urine and hair samples. Extensive epidemiological and clinical data are collected.
Exposure to PM is assigned to each subject using both daily PM10 concentration series from air quality monitors
and pollutant levels estimated by the FARM (Flexible air Quality Regional Model) modelling system and elaborated
by the Regional Environmental Protection Agency.
The recruitment period started in September 2010 and will continue until 2015. At December 31, 2013 we recruited
1250 subjects, of whom 87% lived in the province of Milan.
Primary study outcomes include cardiometabolic and respiratory health effects. The main molecular mechanism we
are investigating focuses on EV-associated microRNAs.
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Discussion: SPHERE is the first large study aimed to explore EVs as a novel potential mechanism of how air
pollution exposure acts in a highly susceptible population. The rigorous study design, the availability of banked
biological samples and the potential to integrate epidemiological, clinical and molecular data will also furnish a
powerful base for investigating different complementary molecular mechanisms. Our findings, if confirmed, could
lead to the identification of potentially reversible alterations that might be considered as possible targets for new
diagnostic and therapeutic interventions.
Keywords: Particulate matter, Obesity, Cardiovascular effects, Extracellular vesicles, Exosomes, Microvesicles, miRNAsBackground
Air pollution is a major health concern which accounts
for ~3.7 million global deaths annually, according to World
Health Organization (WHO) estimates [1].
Numerous health studies have shown acute [2-7] and
chronic [8-10] particulate air pollution exposures to be
associated with early death, particularly from cardiovas-
cular and respiratory diseases [3,10,11]. Metals, which
are constituents of particulate air pollution, have been
shown to be associated with cardiovascular diseases
(CVD) as well [12-31]. Epidemiological and animal stud-
ies have suggested many potential mechanisms by which
particles may impact health. Airway or parenchymal in-
flammatory responses to particulate matter (PM) have
been hypothesized to be the inciting events of a cascade
of pathophysiologic changes in autonomic cardiac, sys-
temic inflammatory, and haemostatic activities. All these
processes may ultimately lead to the acute events associ-
ated with PM exposure [32].
One of the most important gaps in our current know-
ledge regarding PM-related health effects is the identifi-
cation of susceptible subjects [33]. Recent research
findings pointed out obesity as a susceptibility factor to
the adverse effects of PM exposure partly due to an in-
crease in particle absorption [34]. A positive correlation
between exhaled nitric oxide, a marker of pulmonary
inflammation, and Body Mass Index (BMI) has been
shown in healthy adults [35]. BMI was associated with a
graded increase in the estimated total lung dose of de-
posited fine particles in an inhalation study of healthy
children (6–13 years of age) [36]. In a panel study of 44
senior citizens, vascular inflammatory response (mea-
sured by C-reactive protein) to ambient levels of PM2.5
(particulate matter with aerodynamic diameter ≤2.5 μm)
averaged over 1–7 days was greater in obese (BMI ≥30 kg/
m2) than in non-obese subjects [37]. Moreover, a differen-
tial autonomic cardiac response (measured as heart rate
variability) to metal particulates has been observed be-
tween obese and non-obese individuals [33].
The mechanisms linking PM exposure and CVD have
not yet been fully elucidated. It has been proposed that
inhaled fine particulate matter translocates directly into
the systemic circulation through the pulmonary capillarybed, promoting atherothrombosis by breaching endothe-
lial integrity and inciting a local inflammatory reaction
[38]. However, just a very small fraction of these fine
and ultrafine particles accumulate in extra pulmonary
organs such as the liver and the spleen, [39] and cur-
rently there is no final evidence that fine particles phys-
ically enter and deposit in blood vessels. An alternative
hypothesis is that ambient particles produce a strong in-
flammatory reaction in the lungs followed by the release
of pro-inflammatory mediators that are able to reach the
systemic circulation [40,41]. Despite more than two de-
cades of mechanistic research, the recent statement of
air pollution and cardiovascular disease from the American
Heart Association remarked that compared to the high
degree of consistency of the epidemiological findings
showing increased cardiovascular risk, the evidence on
intermediate mechanisms remains moderate or weak [42].
Beside the release of pro-inflammatory mediators, cell-
derived membrane vesicles are also released, represent-
ing another way of intercellular communication that has
recently become the subject of increasing interest [41].
Extracellular vesicles (EVs) are spherical structures lim-
ited by a lipid bilayer that can be generated by cells and
secreted into the extracellular space and are likely com-
posed of both exosomes (EXs) and microvesicles (MVs).
The term exosome is used to identify a particular sub-
group of vesicles, ranging from 40 to 100 nanometers
(nm) in diameter, released as a consequence of multivesi-
cular endosome (a membrane-bound intracellular vesicle,
containing EXs) fusion with the plasma membrane, [43]
whereas the term microvesicle is used for those EVs, larger
than 100 nm in diameter, that are shed from the plasma
membrane.
EVs are released from cell membranes as a conse-
quence of triggers such as endotoxin encounter, hypoxia
or oxidative stress conditions, cytokines release, throm-
bin production [44] and could be one of the means used
by tissues to adapt to these stimuli [45]. EV membranes
are enriched in specific surface molecules which could
favor their capture by recipient cells. The fate of EVs,
after binding the surface of recipient cells, is not known
but recent evidences suggest that they might fuse and de-
liver their content directly into the cytoplasm. In addition,
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expressed ligands, EVs may transfer microRNAs (miR-
NAs) [46,47] allowing intercellular and inter-organ
communication in the body [47]. MiRNAs are small,
endogenous, single stranded noncoding RNAs of 20–22
nucleotides [48] that post-transcriptionally regulate gene
expression by either triggering mRNA cleavage or repres-
sing translation [49]. One single miRNA can regulate hun-
dreds of mRNAs in interrelated gene pathways and a
single mRNA can be targeted by several different miRNAs
[50]. Moreover, miRNA expression in circulating EVs
has been detected in plasma of normal subjects and aFigure 1 Proposed mechanism for air pollution effects on microvesiclpredictive role of peripheral blood miRNA signatures in
human diseases has also been hypothesized [47].Aims and hypotheses
Taken together (Figure 1), these findings suggest that:
– Obese individuals might represent one of the best
population to investigate the effects of
environmental air particles on several molecular
mechanisms and, as a final objective, on
cardiovascular and respiratory parameters;e release and cell-to-cell communication.
Bollati et al. BMC Public Health 2014, 14:1137 Page 4 of 13
http://www.biomedcentral.com/1471-2458/14/1137– EVs might be the ideal candidate mechanism to
mediate the effects of air pollution, since they could
potentially be produced by the respiratory system,
[51,52] reach the systemic circulation [53] and lead
to the development of endothelial dysfunctions [54].
The specific aims of the first funded SPHERE grant
(ERC-2011-StG 282413 to Valentina Bollati), are sum-
marized in Figure 2 and reported below:
1. Determine whether exposure to air particles and
PM-associated metals can modify EVs in plasma
as quantity, size, characterization of the
membrane molecules, procoagulant activity,
miRNA content.
2. Determine whether the changes found in EVs are
associated with CVD risk factors, such as aging,
gender, smoking habits, alcohol consumption, BMI,
blood pressure, medications, lipid metabolism,
glucose homeostasis, homocysteine.
3. Determine whether the changes found in EVs
predict alterations of CVD risk endpoints, such as
inflammation markers (Cytokines), ECG (QRS, PR
waves and heart rate), endothelial function (ICAM-1,
VCAM-1, C-reactive protein), oxidative stress
(8-hydroxy-2′-deoxyguanosine).Figure 2 Conceptual model for the SPHERE study.4. Determine whether exposure to air particles and
PM-associated metals are associated with selected
CVD risk factors (listed in aim 2).
5. Determine whether exposure to air particles and
PM-associated metals predict alterations of CVD
risk biomarkers (listed in 3).
We hereby present study design, field activities, man-
agement organization and characteristics of the enrolled
subjects.
Methods/design
Study design
The SPHERE study is a cross-sectional study investigat-
ing the effects of particulate air pollution on a popula-
tion of susceptible overweight/obese subjects, residing in
Lombardy Region, Italy.
Lombardy is situated in the Northern part of Italy and
is physically divided into three parts from north to
south: Alpine and pre-Alpine mountains, foothills, and a
zone of alluvial plains sloping to the Po river. The region
covers an area of 23.864 km2 with a population of about
10 million people [55] and consists of 12 provinces,
among which Milan is the regional capital. The Milan
metropolitan area counts 7 million inhabitants with 1.3
million residing in the core municipality [56].
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The overall study enrollment target is to recruit 2,000
participants presenting at the Center for Obesity and
Work, Fondazione IRCCS Ca’ Granda Ospedale Maggiore
Policlinico, Milan, Italy. The recruitment period started in
September 2010 and will continue until the end of 2015.
At December 31, 2013 we recruited 1250 subjects, 87% of
whom living in the province of Milan. The eligibility cri-
teria for participants are: 1) older than 18 years at enroll-
ment; 2) obese/overweight according to the following
definition: overweight is defined as a BMI between 25 and
30 kg/cm2, obesity is defined as a BMI of 30 kg/cm2 or
more; 3) resident in Lombardy at the time of the recruit-
ment; 4) agreement to sign an informed consent and do-
nate blood and urine samples.
Exclusion criteria include: previous diagnosis of cancer,
heart disease or stroke in the last year or other chronic
diseases such as multiple sclerosis, Alzheimer’s disease,
Parkinson’s disease, depression, bipolar disorder, schizo-
phrenia and epilepsy [57]. The participation rate in the
years 2010–2013 was 90%. The main characteristics of
study participants are reported in Tables 1 and 2. Most
participants are females (73.6%). The mean BMI is 33.5
Kg/cm2 (±5.5): 27.8% are overweight, 38.6% obese, and
33.6% severe obese (BMI ≥35 Kg/cm2). The mean age is
51.9 years (±13.6).
Epidemiological and clinical data collection
At recruitment, each study subject is asked to:
– fill in a lifestyle and a diet questionnaire,
– donate a 15 ml blood sample (for molecular tests),
– provide a 50 ml urine sample (for metal internal
dose assessment),
– provide a lock of hair cut next to the root in the
occipital area of the head (for metal internal dose
assessment).
As part of the routine protocol, for each subject present-
ing at the Center, physical examination (including weight
and height measured by a nurse following standardized
procedures), spirometry, and electrocardiogram (ECG) are
performed and biochemical parameters are also collected,
including Emocrome, Fibrinogen, C-reactive protein, Total
cholesterol, HDL, LDL, Triglyceride, Serum creatinine,
AST, ALT, Gamma-Glutamyltransferase, fasting blood glu-
cose, Homocysteine, TSH, Glycated haemoglobin, Post-
prandial glycaemia, Insulin level, 2-hour post glucose
insulin level, Urinary pH, Uric acid.
Lifestyle questionnaire
The lifestyle questionnaire collects information on socio-
demographic data, residential area (complete address, char-
acteristics of the house, and traffic), education, smokinghistory including passive smoking at home and at work-
place, past and present health status of both the subjects
and their first-degree relatives, medications in the last year,
employment history and address of the plant of their
current work (currently employed subjects only), physical
activity levels and sedentary behavior, commuting time
and transport mode.
Diet questionnaire
The questionnaire on dietary habits includes questions on
the number of servings from each food in a usual week or
month. Several different types of food are investigated, in-
cluding: legumes, vegetables, fruits, nuts, red and white
meat, fish, eggs, dairy products, cereals, snacks, oil and but-
ter, alcoholic beverage, tea and coffee. Number of servings
from each food are translated into usual daily micronutri-
ents intake weighting for serving size, age class and gender.
Both questionnaires are checked for completeness at
the time of data collection in order to ensure high qual-
ity data.
Lung and cardiac function
Pulmonary functions are measured, at the same day of
blood drawing, with an electronic flow volume spirom-
eter V-max 22 with Autobox (SensorMedics), according
to European Respiratory Society/American Thoracic
Society guidelines (ERS/ATS 2005) [58]. Tests are per-
formed on patients in the sitting position, and are re-
peated until at least three reproducible forced expiratory
curves have been obtained. Lung function parameters
are: forced expiratory volume in one second (FEV1),;
forced vital capacity (FVC); best peak expiratory flow
(PEF); forced expiratory flows at 25%, 50%, and 75% of
FVC (FEF25, FEF50, FEF75); mid-expiratory flow (FEF25–75)
derived from the best maneuver (defined as the one with
the highest sum of FEV1 + FVC). The single breath carbon
monoxide diffusing capacity (DLCO) is also measured [59].
All parameters are expressed as a percentage of the pre-
dicted normal values, [60] and adjusted for sex, age, height.
A resting ECG and rhythm strip is also recorded and
blood pressure is measured with the participant supine,
after 5 minutes of rest.
Biological sample collection
Specific laboratory Standard Operating Procedures have
been developed to ensure quality control of every step
involved in biospecimen collection and storage.
Blood is collected using two EDTA tubes (7 ml) and
one PAX tube. Blood samples are transported from the
Center for Obesity and Work to the Molecular Epidemi-
ology and Environmental Epigenetics laboratory (Univer-
sity of Milan) within 2 hours from the phlebotomy. EDTA
blood is processed to obtain whole blood, buffy coat,
plasma, DNA, EV pellet. EDTA-blood is centrifuged
Table 1 Demographic and lifestyle characteristics of study
participants at 31/12/2013
Characteristics Categories n = 1250
Sex Male 330 (26.4%)
Female 920 (73.6%)
Age Years (mean ± SD) 51.9 ± 13.6
Education Primary school or less 105 (8.4%)
Secondary school 325 (26.0%)
High school 493 (39.4%)
University 188 (15.0%)
Others 87 (7.0%)
Missing 52 (4.2%)
Occupation Employee 714 (57.1%)
Unemployed 102 (8.2%)
Pensioner 304 (24.3%)
Housewife 93 (7.4%)
Missing 37 (3.0%)
Ethnicity White 1198(95.8%)
Black 11 (0.9%)
Asian 3 (0.3%)
South America 38 (3.0%)
Year of enrollment 2010 129 (10.3%)
2011 419 (33.5%)
2012 385 (30.8%)
2013 317 (25.4%)
Season of enrollment Winter 320 (25.6%)
Spring 313 (25.0%)
Summer 190 (15.2%)
Autumn 427 (34.2%)
Smoking Never 599 (47.9%)
Former 431 (34.5%)
Current 190 (15.2%)
Missing 30 (2.4%)
Cigarettes smoked*
[cigarettes/day]
<= 5 53 (27.9%)
5-10 53 (27.9%)
10-15 33 (17.4%)
15-20 37 (19.6%)
20-40 13 (6.8%)
Missing 1 (0.5%)
Time since quitting
(n = 419)
Median [Q1, Q3] 13.1 [5.8–23.4]
Pack/years (n = 1153) Median [Q1, Q3]
Among current and
former smokers
14.5 [6.1–28.0]
Including nonsmokers 0 [0–13.5]
Table 1 Demographic and lifestyle characteristics of study
participants at 31/12/2013 (Continued)
Alcohol consumption Yes 636 (50.9%)
No 518 (41.4%)
Missing 96 (7.7%)
Residence area City 534 (42.7%)
Peripheral area 331 (26.5%)
Rural area 30 (2.4%)
Village/small city 206 (16.5%)
Missing 149 (11.9%)
Living area Province of Milan
(Excluding City of Milan)
379 (30.3%)
City of Milan 713 (57.0%)
Outside Milan 158 (12.7%)
Work area Province of Milan
(Excluding City of Milan)
94 (13.1%)
City of Milan 339 (47.5%)
Outside Milan 34 (4.8%)
Missing 247 (34.6%)
Floor of residence Ground floor 223 (17.8%)
First floor 244 (19.5%)
Second floor 156 (12.5%)
Beyond second floor 471 (37.7%)
Missing 156 (12.5.%)
Residence traffic exposure Mild 108 (8.7%)
Moderate 595 (47.6%)
Heavy 369 (29.5%)
Missing 178 (14.2%)
*Among current smokers; Q1: first quartile; Q3: third quartile.
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platelet-free blood plasma and buffy coat. An aliquot of
plasma is further centrifuged at 1,000, 2,000, and 3,000 × g
for 15 minutes at 4°C to remove cell debris. To prepare
EV pellet, 1.5 mL of fresh plasma is transferred into a
ultracentrifuge tube (Quick-Seal®- Round-Top, Polypropyl-
ene, 13.5 mL-Beckman Coulter, Inc) and filled up with
PBS, filtered with 0.10 μm pore size membrane (StericupR-
VP, 0.10 μm, polyethersulfone filter- Merck Millipore) to
minimalize the background contribution of interfering
particles.
PAX tubes are used for RNA collection and extraction
since they contain a solution that inhibits RNA degrad-
ation and gene induction as blood is drawn into the tube.
A 50 ml urine sample is also collected and frozen
at −20°C.
A lock of hair is cut next to the root in the occipital
area of the head. A segment of 3 cm length is then
washed to remove external contaminations and dissolved
in alkaline solvent.
Table 2 Main clinical characteristics of the study subjects
at December 31, 2013
Characteristics N
BMI, Kg/cm2 1247 33.5 ± 5.5
BMI categorical
<30 Kg/cm2 347 (27.8%)
30-35 Kg/cm2 483 (38.6%)
≥35 Kg/cm2 420 (33.6%)
Waist circumference, cm 1237 101.3 ± 13.1
Blood pressure, mmHg 1247
Sistolic 125.4 ± 15.8
Diastolic 78.5 ± 9.5
Above 140/90 mmHg 60 (4.8%)
Below 140/90 mmHg 1190 (95.2%)
Heart rate, bpm 1243 67.6 ± 10.4
Uric acid 1163 5.2 ± 1.4
Fibrinogen, mg/dl 1129 335 ± 59
C-reactive protein 1160 0.3 [0.1-0.5]
Total cholesterol, mg/dl 1165 215.1 ± 41
HDL 59.2 ± 15.5
LDL 134.7 ± 36.3
Triglyceride 1164 107 [77–145.5]
Serum creatinine, mg/dL 1165 0.8 ± 0.3
AST, U/I 1159 19 [16–23]
ALT, U/I 1160 21 [16–30.5]
Gamma-Glutamyltransferase, IU/L 1162 19 [13–30]
Glucose 1155 92 [86–101]
Homocysteine 1151 10.4 [8.6–12.7]
TSH 1163 1.7 [1.2–2.5]
Glycated hemoglobin, mmol/mol 1159 39 [36.6–43]
Postprandial glycaemia, mg/dl 1162 99 [90–112]
Insulin level 1158 12.3 [8.8–18]
2-hour post glucose insulin level 1155 46.4 [27.6–73]
Urinary pH 1144 5.6 ± 0.7
Emocrome 1156
White blood cells 6.8 ± 1.7
Red blood cells 4.8 ± 0.4
Hemoglobin 13.8 ± 1.4
Hematocrit 40.7 ± 3.4
Mean Corpuscolar Volume 85.1 ± 6.4
Platelets 249.7 ± 59
Continuous variable are expressed as mean ± standard deviation (SD) or as
median [first quartile-third quartile] if not normally distributed; discrete
variables are expressed as counts (%).
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that stores detailed information on sample description,
aliquoting and freezer locations.Approximately 90% of study subjects donated a blood
sample, 99% donated a urine sample and 57% donated a
lock of hair.
Extracellular vesicles and miRNA investigation
In the SPHERE project, we apply a novel methodology
aimed at investigating EVs in human plasma. This com-
prehensive approach, involves the characterization of
microvesicular membrane determinants (to assess their
cellular origin) by Flow Cytometry, microvesicle size and
count by Nanosight (nanoparticle tracking analysis,
NTA), and evaluation of microvesicle content (miRNAs).
For miRNA analysis, we follow a two-stage, split sam-
ple study design. The first (discovery) stage involves
genome-wide miRNA expression profiling among 1,000
participants (the first 1,000 subjects consecutively re-
cruited). The second (validation) stage involves a replica-
tion analysis of the top 50 miRNAs that resulted from
the first stage. In particular, Stage 1 will involve the use
of OpenArray technology (Applied Bioscience) that al-
lows to run 2,688 TaqMan® qPCR reactions in parallel.
In Stage 2, we will replicate the results obtained on the
discovery set by standard real time PCR on an Applied
Biosystems 7900HT Real-Time PCR System. Given the
nature of this study and the lack of prior information on
the investigated association, a formal power calculation
was not possible. A simulation study showed that a sam-
ple size of 1000 subjects allows to obtain a power of 98%
to detect a modest effect (at least 0.1 SD change) on
miRNAs expression, for a 1 SD change in exposure.
Exposure assessment
Exposure is defined using a multifaceted approach, which
integrates information on particulate air pollution expos-
ure with personal dose of metals in urine and hair. In par-
ticular, PM10 is assigned to each subjects following two
approaches: (1) daily PM10 concentration series from air
quality monitors; (2) daily PM10 concentrations estimated
with the FARM (Flexible Air quality Regional Model)
model, a three-dimensional Eulerian grid model for dis-
persion, transformation and deposition of particulates,
capable to simulate PM10 concentration using a 4 km–
dispersion grid [7].
In addition, we will perform personal air pollution
measures of PM (including also PM2.5), using passive
samplers, on a subgroup of selected subjects (n = 200).
Air monitoring stations
We obtained from the Regional Environmental Protec-
tion Agency (ARPA Lombardia) recordings of daily air
levels of PM10 measured from monitoring stations lo-
cated at 154 different sites throughout Lombardy since
2001. Three of them are located in the city of Milan
(“Verziere”, “Pascal-Città Studi” and “Senato”). Nitrogen
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measurements were also available. We used daily con-
centrations measured by single monitors in the study
area to characterize PM10 exposure at the date of re-
cruitment and back to 365 days before enrollment, for
each subject. Thus, we were able to evaluate both short-
and long-term exposure to the investigated pollutant.
We geocoded the addresses of monitoring stations and
study subjects in order to assign to each subject the daily
PM10 concentration from: (1) the nearest monitor to
home address, defined as “subjects’ residence”; (2) the
nearest monitor to the Center for Obesity and Work
(defined as “Policlinico”; (3) the Milan mean daily expos-
ure (averaging the three available city monitors), defined
as “average Milan”.
In case of incomplete series, each missing value was
imputed by using an algorithm that integrates the annual
average of the incomplete series and PM10 concentra-
tions of the nearest and more correlated monitors [61].
About 57% of SPHERE subjects lives in Milan and an
additional 28% works in the city (even if they lived outside
the city); overall 67% of subjects spent many hours a day
in the city or travelling from workplace to residence.
We considered subject PM10 levels measured at the
“Policlinico” station as representative of mean PM10 con-
centrations during the day of enrollment. Moreover, very
high correlation was observed among the three sources of
exposure (RPoliclinico vs Average Milan = 0.99; RSubjects’ Residence vs
Average Milan = 0.94; RPoliclinico vs Subjects’ Residence = 0.99). We
also calculated different lag time exposure windows from
recruitment date using residential and Milan monitors.Figure 3 Graphical representation of PM10 concentration levels. A: Po
Lombardy territory through Empirical Bayesian Kriging (2010–2013). B: PM1To give a map representation of PM10 from monitoring
stations, we applied a geostatistical interpolated method
(Empirical Bayesian kriging) that expands the monitor
PM10 point observations to the whole Lombardy territory
(Figure 3A) [62].
FARM model
Estimated daily average concentrations of PM10 for the
years 2007–2012 based on the FARM model were ob-
tained from ARPA Lombardy. The FARM model is a
chemical transport model able to treat the main pro-
cesses of chemical and physical nature involved in the
formation and removal of pollutants, in addition to their
transport and dispersion due to the action of wind and
atmospheric mixing. The imputed data are built from
meteorological observations of weather and hydrological
network of ARPA and from processing of the results of
the global meteorological model of the ECMWF (European
Centre for Medium-Range Weather Forecasts). The initial
and boundary conditions are obtained from the ARPA net-
work data and the results of the model CHIMERE (http://
www.lmd.polytechnique.fr/chimere/chimere.php). Final-
ly, data on measured and simulated concentrations are
harmonized through interpolation techniques [7,63,64]. By
this model the Lombardy region is divided into a grid of
1678 cells (4×4 km), each associated with daily PM10 con-
centration estimates.
Hence, each subject was attributed the estimated mean
daily exposure of: (1) the cell containing the residential
address; (2) the cell containing the address of the Center
for Obesity and Work; (3) the city of Milan, calculatedint measurements from monitoring stations expanded to the whole
0 concentrations predicted by FARM model (2010–2012).
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boundaries.
Data estimated from the models are currently available
until 2012, since the data validation imply a lag time of
nearly 6 months, and will soon be available for further
data analysis. A map of predicted PM10 concentrations
(2010–2012) is shown in Figure 3B.
Both air quality measuring and modeling have some
degree of uncertainty. Monitoring station measurements
are often hampered by low spatial resolution (point
data). On the other hand, modelling techniques have in-
herent constraints, due to the limited ability to perfectly
describe physical phenomena and the intrinsic variability
of the imputed data [65].
The distribution of daily mean PM10 concentrations
(2010–2012) derived from both the monitoring stations
and the FARM model is reported in Figure 4. PM10 esti-
mates have, on average, lower values than measured
concentrations (see also Additional file 1: Figure S1).
During winter months (October to February) this differ-
ence is more evident (see also Additional file 2: Table S1).
FARM model performance was examined using a stand-
ard performance metric: the Mean Fractional Bias (MFB),
which is a measure of the model tendency to over- or
under-predict the observations from monitors. The MFB
is defined as the normalized average difference between all
model-observed pairs and can vary between ±200%. The
model performance goal is met when the MFB is be-
tween ±30% [65,66]. We obtained MFB = −16% for the
entire period of comparison and year specific MFBs
remained within the range. These results suggest the ful-
fillment of the objective of performance, confirm the ten-
dency to underestimate the measured concentrations, andFigure 4 Estimated and observed daily mean PM10 concentrations (20
grid cells with a monitor falling into their boundary. Darker area highlights
methods of exposure assessment.are consistent with the ARPA Lombardy Annual Assess-
ment Of Air Quality Modeling for years 2009–2011 [64].
According to the Italian Legislative Decree 13 August,
2010, nr. 155 (Annex I), implementing the European
Union Directive 2008/50/EC, ratios between measured
and estimated data must be between ±50% in order to
consider the data quality as acceptable [64,67]. Our cal-
culated ratios all fell in the data quality range, except for
three monitors not linked to any subjects’ residence (see
Additional file 1: Figure S2). Analyses performed for
each year and over the entire time period gave compar-
able results.
In interpreting the above listed exposure assessment
findings, it is important to consider that measurements
from monitoring stations should not necessarily be con-
sidered as the gold-standard. The differences between
the measured and estimated air pollutant levels may be
partially explained by the fact that a point measurement
is compared to a mean concentration modeled in volu-
metric grid cell. The former unlikely represents the aver-
age concentration over the same volume of air, making
it difficult to obtain a perfect match between the two
methods. The ability of the model to deeply take into ac-
count meteorological variables could also play an im-
portant role [65].
Internal dose of metals/elements
As part of the routine protocol, for each subject present-
ing at the center a 50 ml urine sample and a hair sample
are collected, in order to quantify metals in urine and
hair. Urine gives short term information (few hours be-
fore sample collection). Hair is also regarded as a valu-
able matrix as during its growth (about 1 cm per month)10–2012). Daily mean PM10 concentrations of all monitors and of all
winter months, characterized by major differences between the two
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hair (a 3 cm-length segment), cut next to the root in the
occipital area of the head, roughly corresponding to
3 months of exposure. The parallel quantification of
metals in urine and hair gives complementary data on
medium- and short-term exposure. Trace metals/elements
measured by ICP/MS include: Aluminum, Antimony,
Arsenic, Beryllium, Bismuth, Cadmium, Lead, Mercury,
Platinum, Thallium, Uranium, Nickel, Silver, Titanium,
Calcium, Magnesium, Sodium, Potassium, Copper, Zinc,
Manganese, Chromium, Vanadium, Molybdenum, Boron,
Iodine, Lithium, Phosphorus, Selenium, Strontium, Sulfur,
Barium, Cobalt, Iron, Germanium, Rubidium, Zirconium.
Ethical issues
The study design, research aims and measurements have
been approved by the local Institutional Review Board
(‘Fondazione IRCCS Cà Granda Ospedale Maggiore Poli-
clinico’ review board).
Each participant was asked to sign a written informed
consent explaining the study in detail. New measure-
ments will only be embedded in the study after approval
of the Ethical Committee.
Data management and privacy protection
A study collecting a large amount of information which
are updated daily, such as SPHERE, requires highly effi-
cient data management systems.
In order to protect the privacy of each subject, all infor-
mation and biological samples collected from the subject
are anonymized of personally identifying information and
will be identified only through a 5-digit randomly assigned
barcode. The link between the barcode and the subject’s
identity is held in a secure database.
All questionnaire data collected through paper forms,
are imputed in the database and quality and complete-
ness control are performed weekly. All data are com-
bined in a central relational database (MS SQL Server).
Data processing is anonymous and the highest level of
confidentiality is maintained for all identifying informa-
tion. We routinely check quality of collected data by
comparing information from different sources (e.g. ques-
tionnaires, clinical records, biochemical exams); asses-
sing variable range and distribution; evaluating the
quality of biospecimens through specific analyses con-
ducted on random samples; and verifying the database
completeness through multiple queries.
A complete list of all collected variables is reported in
Additional file 2: Table S2.
Dissemination of results
A project’s website is being implemented and will be up-
dated regularly (http://users.unimi.it/sphere). It will con-
tain complete information about the project and relevantevents. All publishable material and reports will be put on-
line as they are produced. The results from the project will
be converted into user-friendly protocols and published in
press releases, educational programs, conferences, and sci-
entific journals.
Opportunities to collaborate
We designed SPHERE being aware that much of its
value would arise from involvement with other investiga-
tors, individually and within consortia. The SPHERE
project is open for collaboration with interested investi-
gators. Given the detailed epidemiological data available,
such as the clinical information collected, and the mo-
lecular data, SPHERE will provide a good environment
for collaborations. Proposals from outside the study
team for research projects to test specific hypotheses on
SPHERE population will be reviewed by our research
team. Requests can be sent to the e-mail sphere@unimi.it.
Discussion
The investigation of mechanisms linking air pollutant in-
halation to cardiovascular effects is being considered a
pressing priority [40,68].
The SPHERE study is, at the best of our knowledge, the
first study primarily designed to determine whether expos-
ure to air particles and PM-associated metals can modify
EVs (as quantity, size, membrane molecules, procoagulant
activity and miRNA content) in plasma of human subjects
and to investigate whether these alterations may be linked
to cardiovascular risk factors and outcomes.
The identification of miRNAs in plasma EVs of healthy
subjects [47] provides the basis for a new potential mech-
anism, since EVs produced by lung or dendritic cells might
be able to transfer a specific pattern of miRNAs to im-
mune and endothelial cells.
We will be able to examine the above mentioned
mechanism in a large group of human subjects particu-
larly susceptible to the effects of air pollution, measuring
EV production and content (miRNAs) in plasma. For
this purpose, we developed a novel methodology which
involves the characterization of microvesicular membrane
determinants (to assess their cellular origin) by Flow cy-
tometry, microvesicle sizing and counting by Nanosight
technology, and microvesicle content (miRNAs) analysis
by highly quantitative OpenArray technology (Quant Stu-
dio, Applied Bioscience). Openarray technique will allow
to analyze, in an unbiased way, the entire miRNome in
one single reaction and will produce very precise and ac-
curate data. Moreover, the inclusion in the study protocol
of a discovery stage (1000 samples) followed by a confirm-
ation stage (1000 samples), will lower the possibility to
find false positive results.
Thus, if we were successful in identifying miRNA al-
terations in EVs, we could detect the opportunity of
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potential future preventive and diagnostic applications.
In addition, as miRNAs in EVs may be a possible drug
target, our study might also open paths to develop future
interventions to reverse the effects of air pollution.
The extensive clinical and biochemical data collected
for each subject will help in examining the relationships
under study taking into account the possible role of
other covariates.
The characterization of subjects’ exposures can rely on
various sources of exposure assessment: monitoring sta-
tions, personal samplers, model estimates, and internal
dose measurements.
The availability of PM measurements from past years
and the use of diverse lag-time windows will allow to in-
vestigate both long- and short-term exposure effects.
Residential, workplace and mobility information col-
lected through questionnaires will improve the accuracy
of subject-specific exposure assessment.
A further validation of the exposure indexes will be
provided by the use of passive samplers in a subgroup of
subjects. We will also integrate all the information with
urine and hair metal measurements.
Finally, the huge amount of available data will offer
the opportunity to implement further new modelling
techniques as long as they might come out.
In conclusion, SPHERE is the first large study aimed
to explore EVs as a novel potential mechanism of action
of air pollution exposure in a highly susceptible popula-
tion. The rigorous study design, the availability of banked
biological samples and the potential to integrate epidemio-
logical, clinical and molecular data will also furnish a
powerful base for investigating different complementary
molecular mechanisms.
Additional files
Additional file 1: Figure S1. Estimated and observed mean PM10 level
by place. Figure S2. Data quality control on FARM model estimates
(2010–2012) according to EU Directive 2008/50/EC. Each point represents
PM10 mean concentrations as measured by monitoring stations (x axis)
and estimated by FARM model in the corresponding cells (y axis). The
cone dotted lines delimit the ±50% range of data quality.
Additional file 2: Table S1 PM10 profile (overall and by season) and
selected weather variables (2010–2012). All values are calculated at the
time of blood sampling. Table S2. Complete list of variables collected for
the SPHERE study.
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